These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28182344)

  • 1. Clinical Implication of Cystatin C and β2-Microglobulin in Early Detection of Diabetic Nephropathy.
    Chen H; Li H
    Clin Lab; 2017 Feb; 63(2):241-247. PubMed ID: 28182344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
    Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
    Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q; Wang M; Xu T; Liang W; Yang F
    J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C as an early marker of nephropathy among type 2 diabetics: A meta-analysis.
    Arceo ES; Dizon GA; Tiongco REG
    Diabetes Metab Syndr; 2019; 13(6):3093-3097. PubMed ID: 31778883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.
    Li M; Fan R; Peng X; Huang J; Zou H; Yu X; Yang Y; Shi X; Ma D
    Front Endocrinol (Lausanne); 2021; 12():695750. PubMed ID: 34603198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high triglyceride glucose index is associated with early renal impairment in the hypertensive patients.
    Dong J; Yang H; Zhang Y; Chen L; Hu Q
    Front Endocrinol (Lausanne); 2022; 13():1038758. PubMed ID: 36589813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Retinopathy in the Detection of Diabetic Nephropathy in Type 2 Diabetes: A Systematic Review and Meta-Analysis of 45 Studies.
    Jiang S; Yu T; Zhang Z; Wang Y; Fang J; Yang Y; Liu L; Li W
    Ophthalmic Res; 2019; 62(2):68-79. PubMed ID: 31256153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy.
    Pan L; Ye Y; Wo M; Bao D; Zhu F; Cheng M; Ni X; Fei X
    Dis Markers; 2018; 2018():5214376. PubMed ID: 29511389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
    Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
    J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.